Rioux Patriceinsider trades

In SEC Form 4 filings, Rioux Patrice is listed as Reporting owner of Monopar Therapeutics (MNPR). In the last 90 days, Rioux Patrice sold $111.26 of Monopar Therapeutics (MNPR) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
MNPRMonopar Therapeutics	Reporting owner	3	Aug 27

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-27

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
MNPRMonopar Therapeutics	Aug 26	Aug 27	M	1,380	$0.01	$7	5,066	Yes	Form 4
MNPRMonopar Therapeutics	Aug 26	Aug 27	S	1	$111.26	Sale −$111	5,065	Yes	Form 4
MNPRMonopar Therapeutics	Aug 26	Aug 27	M · derivative	1,380	$0.01	$7	not reported	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.